Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Comparative Validation Study of RUCAM and RECAM

NCT06771011 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT06771011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06771011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Comparative Validation Study of RUCAM and RECAM
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2023
Completion date
May 1, 2026
Enrollment
407 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug induced liver injury